Additive Solutions for the Suspension of Blood Products Framework Agreement

Description

Establishment of a Framework Agreement with the following Blood Establishments as<br/>beneficiaries - NHS Blood and Transplant; the Welsh Blood Service (WBS); the Northern<br/>Ireland Blood Transfusion Service (NIBTS); the Scottish National Blood Transfusion Service<br/>(SNBTS); the Australian Red Cross Lifeblood (ARCL), the New Zealand Blood Service<br/>(NZBS) and the Irish Blood Transfusion Service (IBTS).<br/>Additive Solutions for the Suspension of Blood Products:<br/>Lot 1: Additive solution for the suspension of pooled platelets, granulocytes and other<br/>components derived from whole blood; Additive solution for the suspension of single donor<br/>apheresis derived platelets;<br/>Lot 2: SAGM solution for the routine washing and re-suspension of red cells<br/>during the production of specialist blood components in accordance with the Guidelines for<br/>the Blood Transfusion Services in the UK details of which can be found at the following<br/>website https://www.transfusionguidelines.org/red-book Lot Lot 1: Lot 1 Platelet Additive Solution (PAS-E) PAS-E. Additive solution for the suspension of pooled platelets (derived from whole blood),<br/> granulocytes and other components. Additive Solution for the suspension of single donor<br/> apheresis derived platelets. Lot Lot 2: Lot 2 Saline Adenine Glucose Mannitol (SAG-M) SAG-M solution for the routine washing and re-suspension of red cells during the production of specialist blood products in accordance with the Guidelines for the Blood Transfusion Services in the UK details of which can be found at the following website www.transfusionguidelines.org/red-book